| First Author | Manenti G | Year | 1996 |
| Journal | Nat Genet | Volume | 12 |
| Issue | 4 | Pages | 455-7 |
| PubMed ID | 8630506 | Mgi Jnum | J:32079 |
| Mgi Id | MGI:79582 | Doi | 10.1038/ng0496-455 |
| Citation | Manenti G, et al. (1996) Genetic mapping of a pulmonary adenoma resistance (Par1) in mouse. Nat Genet 12(4):455-7 |
| abstractText | Lung cancer, a major cause of death in the Western world, has a poor prognosis. So far, therapeutic strategies have had only a limited effect. Lung cancer risk is strongly associated with cigarette smoking and lung cancer pedigrees are rare. However, a possible polygenic nature of inherited predisposition to this cancer has been envisaged. Mouse inbred strains with inherited predisposition and resistance to lung cancer provide an important tool for the dissection of the genetics of this complex disease. The A/J strain carries the pulmonary adenoma susceptibility 1 (Pas1) locus and develops many lung tumours. We have mapped the M. spretus-derived locus that strongly resists the lung tumorigenesis in Pas1/+ mice. This locus, pulmonary adenoma resistance 1 (Par1) maps to mouse chromosome 11, near the Rara locus, with a lod score of 5.3. In Pas1/+ mice Par1 accounts for 23% of the phenotypic variance and 10 fold reduction in total tumour volume. These results provide evidence for a major resistance locus affecting the expression of an inherited predisposition to lung cancer. |
